Premium
At the Bedside: CTLA‐4‐ and PD‐1‐blocking antibodies in cancer immunotherapy
Author(s) -
Callahan Margaret K.,
Wolchok Jedd D.
Publication year - 2013
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.1212631
Subject(s) - ipilimumab , ctla 4 , immunotherapy , blocking antibody , cancer immunotherapy , blockade , antibody , immune system , immunology , immune checkpoint , cancer , pd l1 , biology , monoclonal antibody , receptor , cancer research , medicine , t cell
Clinical Review for Basic Researchers: Treating patients with CTLA‐4 and PD‐1 pathway blocking antibodies, plus clinical progress and application of agents in earlier stages of development.